Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mcla-128 (1 trial)
trastuzumab (herceptin) (1 trial)
vinorelbine (navelbine) (1 trial)
mcla-158 (1 trial)
Breast Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (4 total)